Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zaina T Al-Salama

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Drugs|September 7, 2019
Apalutamide: A Review in Non-Metastatic Castration-Resistant Prostate CancerZaina T Al-Salama
Targeted Oncology|December 6, 2021
Correction to: Durvalumab: A Review in Extensive-Stage SCLCZaina T Al-Salama
Drugs|May 31, 2019
Siponimod: First Global ApprovalZaina T Al-Salama
Drugs|September 24, 2017
Elsulfavirine: First Global ApprovalZaina T Al-Salama
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 4, 2019
FKB327: An Adalimumab BiosimilarZaina T Al-Salama
Targeted Oncology|November 3, 2021
Durvalumab: A Review in Extensive-Stage SCLCZaina T Al-Salama
Drugs|January 10, 2019
Emapalumab: First Global ApprovalZaina T Al-Salama
Drugs|October 15, 2020
Imlifidase: First ApprovalZaina T Al-Salama
Drugs|April 29, 2021
Encorafenib: A Review in Metastatic Colorectal Cancer with a BRAF V600E MutationZaina T Al-Salama
Drugs|April 8, 2018
Apalutamide: First Global ApprovalZaina T Al-Salama
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Drugs|September 7, 2019
Apalutamide: A Review in Non-Metastatic Castration-Resistant Prostate CancerZaina T Al-Salama
Targeted Oncology|December 6, 2021
Correction to: Durvalumab: A Review in Extensive-Stage SCLCZaina T Al-Salama
Drugs|May 31, 2019
Siponimod: First Global ApprovalZaina T Al-Salama
Drugs|September 24, 2017
Elsulfavirine: First Global ApprovalZaina T Al-Salama
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 4, 2019
FKB327: An Adalimumab BiosimilarZaina T Al-Salama
Targeted Oncology|November 3, 2021
Durvalumab: A Review in Extensive-Stage SCLCZaina T Al-Salama
Drugs|January 10, 2019
Emapalumab: First Global ApprovalZaina T Al-Salama
Drugs|October 15, 2020
Imlifidase: First ApprovalZaina T Al-Salama
Drugs|April 29, 2021
Encorafenib: A Review in Metastatic Colorectal Cancer with a BRAF V600E MutationZaina T Al-Salama
Drugs|April 8, 2018
Apalutamide: First Global ApprovalZaina T Al-Salama
Pageof 3